Lung Diseases Clinical Trial
Official title:
Palliative Care Coaching for Family Caregivers & Patients With Rare Advanced Lung Disease
With one of the highest incidences of lung disease deaths in the nation, there is great need for home end-of-life palliative care in the rural, disadvantaged communities of West Virginia. The aims of this proposed study are to: (1) pilot test the nursing care intervention with patients and family members managing home supportive EOLPC for rare advanced lung disease and (2) collect research data to report in the NIH resubmission and future trials.
Nearly 15 million Americans and greater than 10% of West Virginia (WV) residents live with
and eventually die from Rare and Advanced Lung Diseases (R-ALD), including pneumoconiosis
(i.e., dust, asbestos), and idiopathic pulmonary fibrosis. Patients with R-ALD experience
refractory breathlessness, depression, fatigue, and extreme worry about their family members
and cost of health care. With one of the highest incidences of lung disease deaths in the
nation, there is great need for home EOLPC in the rural, disadvantaged communities of WV. The
proposed EOLPC intervention (FamPALcare) is based on R-ALD experts' input, national EOLPC
guidelines, and the PI's published EOLPC studies with breathlessness in end-stage heart
failure (HF) patients.
This project is well-aligned with the National Institutes of Health (NIH) priority specific
to "Appalachian populations experiencing extreme inequities and poor access to healthcare"
and the NIH PAR on palliative care for family caregivers and patients with advanced lung
diseases. The PI's NIH application review, which received a positive score, stated that this
project will have a high impact on improving palliative care for rural families managing lung
disease and the project can be translated to other rural communities. This is an initial
study of coaching home-based palliative R-ALD care in rural Appalachia. The NIH review stated
using the PI's culturally sensitive approaches for R-ALD was novel for chronic lung disease.
Also, addressing both family caregivers' and patients' needs was noted as innovative and
increased the potential for future funding, as was the rigorous protocol for observing
intervention fidelity.
This study uses a random control group comparison design to test the implementation of the
FamPALcare intervention with R-ALD patients and their primary family caregiver. Specific aims
are to: (1) pilot test the FamPALcare nursing care intervention with patients and family
members managing home supportive EOLPC for R-ALD and (2) collect research data to report in
the PI's NIH resubmission and future trials. The control patients receive standard care given
through the WVU hospital and outpatient clinics, prescribed by the patient's pulmonologist,
and recorded in the medical record. The FamPALcare intervention group receives all standard
care plus 2 weeks of home EOLPC coaching by community nurses experienced in EOLPC. Data will
be collected at baseline, month one, and month three from patients and caregivers
independently. This pilot study provides testing of our research guides and procedures that
will be described to enhance the NIH resubmission and will determine power needed for the
future RCT design.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04908397 -
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
|
Phase 1 | |
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT03682354 -
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Completed |
NCT02926768 -
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Completed |
NCT00269256 -
Stress, Environment, and Genetics in Urban Children With Asthma
|
N/A | |
Completed |
NCT00281216 -
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
N/A | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Active, not recruiting |
NCT00115297 -
Montelukast for Early Life Wheezing
|
Phase 2/Phase 3 | |
Completed |
NCT00094276 -
Intervention for Improving Asthma Care for Minority Children in Head Start
|
N/A | |
Completed |
NCT00091767 -
Genetic Studies in Difficult to Treat Asthma: TENOR
|
N/A | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT00233168 -
Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents
|
N/A | |
Completed |
NCT00069823 -
Study of Acid Reflux in Asthma
|
Phase 3 |